Bluestein R H & Co. lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 96.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,051 shares of the medical equipment provider’s stock after selling 31,590 shares during the period. Bluestein R H & Co.’s holdings in Intuitive Surgical were worth $1,099,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the company. Private Advisor Group LLC raised its stake in shares of Intuitive Surgical by 282.9% in the 3rd quarter. Private Advisor Group LLC now owns 4,981 shares of the medical equipment provider’s stock valued at $1,793,000 after acquiring an additional 3,680 shares during the period. Stifel Financial Corp raised its stake in shares of Intuitive Surgical by 47.3% in the 3rd quarter. Stifel Financial Corp now owns 12,308 shares of the medical equipment provider’s stock valued at $10,544,000 after acquiring an additional 3,952 shares during the period. Skandinaviska Enskilda Banken AB publ raised its stake in shares of Intuitive Surgical by 4.9% in the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 6,458 shares of the medical equipment provider’s stock valued at $2,251,000 after acquiring an additional 300 shares during the period. KBC Group NV raised its stake in shares of Intuitive Surgical by 9.5% in the 3rd quarter. KBC Group NV now owns 5,818 shares of the medical equipment provider’s stock valued at $2,028,000 after acquiring an additional 504 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in shares of Intuitive Surgical by 0.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 64,903 shares of the medical equipment provider’s stock valued at $67,869,000 after acquiring an additional 276 shares during the period. 32.81% of the stock is currently owned by institutional investors and hedge funds.
A number of equities research analysts recently weighed in on ISRG shares. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 10th. Barclays reaffirmed an “overweight” rating on shares of Intuitive Surgical in a report on Friday, October 20th. Zacks Investment Research lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Monday, November 13th. Vetr raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $113.59 price target for the company in a report on Monday, August 28th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $333.33 price target on shares of Intuitive Surgical in a report on Friday, September 1st. Five analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Intuitive Surgical has an average rating of “Buy” and a consensus price target of $155.78.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.99 by $0.78. The company had revenue of $806.10 million during the quarter, compared to analyst estimates of $753.25 million. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. The firm’s revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period last year, the business earned $2.06 EPS. research analysts anticipate that Intuitive Surgical, Inc. will post 7.85 EPS for the current year.
In other Intuitive Surgical news, CFO Marshall Mohr sold 6,000 shares of the firm’s stock in a transaction on Monday, October 30th. The shares were sold at an average price of $372.22, for a total transaction of $2,233,320.00. Following the completion of the transaction, the chief financial officer now directly owns 12,316 shares of the company’s stock, valued at approximately $4,584,261.52. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Salvatore Brogna sold 6,082 shares of the firm’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $397.61, for a total transaction of $2,418,264.02. Following the transaction, the chief operating officer now directly owns 3,096 shares of the company’s stock, valued at $1,231,000.56. The disclosure for this sale can be found here. Over the last three months, insiders have sold 55,944 shares of company stock valued at $21,432,971. 2.20% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This story was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.chaffeybreeze.com/2017/12/05/bluestein-r-h-co-cuts-stake-in-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.